Efficacy and safety of tildrakizumab 100 mg for plaque psoriasis in patients randomized to treatment continuation vs treatment withdrawal with retreatment upon relapse in reSURFACE 1. (12th February 2021)

Record Type:: Journal Article
Title:: Efficacy and safety of tildrakizumab 100 mg for plaque psoriasis in patients randomized to treatment continuation vs treatment withdrawal with retreatment upon relapse in reSURFACE 1. (12th February 2021)
Main Title:: Efficacy and safety of tildrakizumab 100 mg for plaque psoriasis in patients randomized to treatment continuation vs treatment withdrawal with retreatment upon relapse in reSURFACE 1
Authors:: Cantrell, W.
Lee, P.
Mendelsohn, A.M.
Rozzo, S.J.
Liao, W.
Abstract:
Is Part Of:: Journal of the European Academy of Dermatology and Venereology. Volume 35:Number 8(2021)
Journal:: Journal of the European Academy of Dermatology and Venereology
Issue:: Volume 35:Number 8(2021)
Issue Display:: Volume 35, Issue 8 (2021)
Year:: 2021
Volume:: 35
Issue:: 8
Issue Sort Value:: 2021-0035-0008-0000
Page Start:: e526
Page End:: e528
Publication Date:: 2021-02-12
Subjects:: Dermatology -- Periodicals
Sexually transmitted diseases -- Periodicals
616.5
Journal URLs:: https://onlinelibrary.wiley.com/journal/14683083 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=jdv ↗
http://www.sciencedirect.com/science/journal/09269959 ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0926-9959;screen=info;ECOIP ↗
http://www.blackwell-synergy.com/loi/jdv ↗
DOI:: 10.1111/jdv.17124 ↗
Languages:: English
ISSNs:: 0926-9959
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4741.624000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 17565.xml